Tania

[European Atherosclerosis Society @society_eas]

In line with the Safe Hearts Plan ♥️, and building on the Commission’s vision for personalised prevention, EAS, Lp(a) and FHEF stand ready to support the development of an EU Protocol on Cardiovascular Health Checks that integrates early-life screening into a coherent lifecourse approach. Such a protocol should include systematic lipid screening for children in the first decade of life, integrated into existing child health and vaccination programmes; measurement of a full lipid profile including LDL cholesterol, Lp(a) and triglycerides; family-based cascade and reverse-cascade testing; and seamless integration with adult cardiometabolic health checks.

Digital tools and artificial intelligence, aligned with the European Health Data Space, should be used to support risk prediction and personalised prevention, while ensuring transparency, explainability and clinician-mediated decision-making, in line with patient trust and ethical standards.

This approach is fully aligned with findings from Commission co-funded projects, including PERFECTO FH and FH-EARLY, and supports the Plan’s objectives to reduce inequalities, improve outcomes and strengthen health system sustainability.

📄 Read the full statement: https://t.co/EJ5voMcaBb @magdadaccord @fhpatienteurope @KronenbergLab @ProfKausikRay @KatiOorni

[Cherska Mariia @cherskams]

FH worldwide: what’s the current status & how can implementation science help us improve?

📅 Sept 24 | 17:00–18:00 CET
🎙 Prof. Kirsten Holven & Prof. Gerald Watts
✅ Free registration

#FHWeek #FHSC #FamilialHypercholesterolemia #Cardiology #HeartHealth

[European Atherosclerosis Society @society_eas]

Prof. Šekib Sokolović emphasizes the importance of proper dissemination of the Focused Update of the 2019 ESC/EAS Guidelines at local levels. Learn more about the key messages yourself: https://t.co/62vUMYKEV0

[Alexander Bartelt @BarteltLab]

On my way to Lake Starnberg now - excited for an outstanding program featuring 80% of talks by junior investigators and 70% of all presenters are female!

Thanks to @society_eas, our sponsors, and especially @TaniaBoerjesson our administrator!

[Cherska Mariia @cherskams]

🚨 New release!
The 2025 Focused Update of the 2019 ESC/EAS Guidelines on dyslipidaemia management is out.
Latest evidence → better prevention & treatment of ASCVD.

🔗 https://t.co/P3Pf01BL05

#Cardiology #EAS #ESC #Dyslipidaemia

[Pablo Corral MD @drpablocorral]

🚨 2025 ESC/EAS Focused Update on Dyslipidaemias 🚨

Key practice-changing highlights:

🔹 New SCORE2 & SCORE2-OP risk algorithms
🔹 Introduction of bempedoic acid and evinacumab for LDL-C lowering
🔹 Early, intensive lipid-lowering therapy recommended in ACS during index hospitalization
🔹 Lp(a) >50 mg/dL (≥105 nmol/L) recognized as a risk modifier
🔹 Updated recommendations on hypertriglyceridaemia including novel RNA-based therapies
🔹 Strong evidence for statins in people with HIV (REPRIEVE trial)
🔹 Guidance for cancer patients at high CV risk under chemotherapy
🔹 Clear statement: dietary supplements show no proven CV benefit

📌 A step forward towards more personalized and aggressive prevention in high-risk patients.

https://t.co/XWG2s4QaEO

@society_eas
@escardio
@ATHjournal

[European Atherosclerosis Society @society_eas]

We are pleased to announce that the European Society of Cardiology (ESC), together with the European Atherosclerosis Society (EAS), has published the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: https://t.co/7KcqJjRchA

Since the publication of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular (CV) risk, there have been several randomized controlled trials that might change patient management ahead of the next scheduled full dyslipidaemia Guidelines.

This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published up until March 31, 2025. @ProfKausikRay @KatiOorni

[European Atherosclerosis Society @society_eas]

ESC Congress 2025 begins this Friday! EAS is delighted to contribute to the scientific programme with key sessions. Discover what’s coming up soon:

📗 29 August • 08:15 - 09:45, 2025 ESC Guidelines and Document overview
📗 29 August • 11:00 - 12:00, Obesity and systemic metabolic disorders: burden, staging, and management, Joint session with the European Atherosclerosis Society (EAS)
📗 31 August • 11:00 - 12:00, 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
📗 31 August • 17:30 - 18:30, 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Ask the Task Force
📗 1 September • 11:00 - 12:00, Guidelines in Practice: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias @ProfKausikRay @KatiOorni

[European Atherosclerosis Society @society_eas]

🎓 Join the 18th Summer School on Secondary Dyslipidemias!
📍 Syros, Greece
📅 June 6–7, 2025

This EAS-endorsed meeting, organised by the Hellenic Atherosclerosis Society, offers expert lectures and interactive workshops on the causes, diagnosis, and treatment of secondary dyslipidemias — with a special focus on therapeutic strategies and the role of nutrition.

This course is particularly relevant for our Greek members.

🔗 More info & registration: https://t.co/AgbVFoaF0F
🔗 Learn about the benefits of being a National Society member of EAS: https://t.co/RYOcqaN9ee

@fotisbarkas @ELiberopoulos @MeralKayikcoglu @HellenicAthero

[European Atherosclerosis Society @society_eas]

📢 1 week to go – don’t miss out!
Join Professor Pablo Corral and leading experts for the EAS Advanced Course on Rare Lipid Disorders: Bridging Knowledge and Clinical Practice in LatAm

🗓️ Date: 11 June 2025
🕓 Time: 16:00 ART
🌐 Language: Spanish

✅ Deep dive into genetics, diagnosis & treatment
✅ Regionally relevant strategies
✅ Expert-led, practical insights

🎓 Register now: https://t.co/zaI9x62AQZ
📄 Full programme: https://t.co/F3hSDPhsY5

👉 Strengthen your clinical skills with Pablo Corral, Raul Santos, Juan Patricio Nogueira, Rodrigo Alonso Karlezi, Laura Schreier & Carlos Alberto Aguilar Salinas

[European Atherosclerosis Society @society_eas]

📢 New FREE training modules developed by EAS Paediatric FH Working Group experts!

The Royal College of Paediatrics and Child Health (RCPCH) has launched two new online modules to help healthcare professionals identify and manage Heterozygous Familial Hypercholesterolaemia (HeFH) in children and young people.

🧬 Developed by Prof Steve Humphries and Dr Uma Ramaswami — both members of the EAS Paediatric FH Working Group — together with Dr Neil Hopper, these modules respond to the urgent need for better awareness and care for children with FH.

🎓 Free access via RCPCH:
👉 https://t.co/MQGTzb3jgv

[Pablo Corral MD @drpablocorral]

👉Curso @society_eas Dislipidemias Raras o poco frecuentes

🙌Imperdible actividad en español!

📆 11 Junio 16 hs. (ART)

☝️Actividad no arancelada

👨🏻‍⚕️🧑🏻‍⚕️Con la participación de un cuerpo docente de primer nivel
@rauldsf_santos
@lschreier1
@KarleziAlonso
@juanPat01592525
@caguilarsalinas

🔗Link de inscripción
https://t.co/UCobmYZvJV

[European Atherosclerosis Society @society_eas]

🚨 Register now!
We are pleased to launch a new series of Advanced Courses on Non-Classical Risk Factors for Cardiovascular Disease!

🧠 Learn about emerging drivers of CVD beyond the usual suspects:
✨ Chronic inflammation
✨ Gut microbiota
✨ Psychosocial stress
✨ Environmental & metabolic factors

Taught by leading experts – connect with peers, explore new science, and advance your knowledge!

📍 Locations: Sweden | Austria | Italy | UK
📅 Limited spaces – secure your spot today!
🔗 https://t.co/nihSIAXRsD

@stefano_romeo76 @HolvenKirsten @cj_binder @ZMallat @DaniloNorata

[European Atherosclerosis Society @society_eas]

🧬 EAS Advanced Course on Rare Lipid Disorders: Bridging Knowledge and Clinical Practice in Latin America

Are you a clinician or healthcare professional in LatAm working in lipidology or cardiovascular care?

Join our free online course to deepen your understanding of rare lipid disorders—from genetics to diagnosis and treatment—tailored to the regional needs and realities of Latin America.

📌 Course highlights:
🔹 Genetic diagnosis and its clinical relevance
🔹 Impact on cardiovascular and metabolic health
🔹 Real-world clinical cases from Latin America
🔹 Strategies for regional collaboration and care

📅 Date: June 11
🌐 Format: Online
🗣️ Language: Spanish
🎓 Certificate of participation included
📃 Programme & more info: https://t.co/F3hSDPhsY5

✅ Free registration now open: https://t.co/zaI9x62AQZ'

Let’s work together to improve the early detection and care of rare lipid disorders in Latin America.

@drpablocorral @rauldsf_santos @JuanPatricioNo1 @KarleziAlonso Laura Schreier @caguilarsalinas

[SABOURETCardiologist @SABOURETCardio]

#EASCongress2025 great team with Tania Borjesson and Matheus Van Tol. ☀️☀️

[Federica Fogacci @FedericaFogacci]

The scientific program of the EAS Paediatric FH Symposium is out! Like every year, the Workshop will be held on in conjunction w/ the EAS Congress - so, if you are interested in the topic, organize your trip so as not to miss it! ✈️🏴󠁧󠁢󠁳󠁣󠁴󠁿
🔗https://t.co/5HtoB8cDew
@society_eas @j_rvl

[European Atherosclerosis Society @society_eas]

Our President-Elect Prof. @BNordestgaard shares why submitting your abstract for #EASCongress2025 is an opportunity you don't want to miss. Watch this inspiring video and take action today: https://t.co/2LVswhFe4E

[European Atherosclerosis Society @society_eas]

Exciting day! The Executive Committee meets today for the first time with our newly elected members to shape the future strategy YOU voted for in the EAS Elections. Stay tuned for updates as we work together to take EAS forward! @ProfKausikRay @BNordestgaard

[European Atherosclerosis Society @society_eas]

The call for Anitschkow Prize 2025 nominations is now open! This esteemed prize, presented annually by the EAS, honors outstanding researchers who have made significant contributions to the field of atherosclerosis and related metabolic disturbances. https://t.co/9pnilOjRQ7

[Dr Meral Kayikcioglu @MeralKayikcoglu]

Don’t miss! Liver & cardiometabolic syndrome @escardio @society_eas joint session 31 August at 17:30 Room Rabat 🙏🫀🙋🏻‍♀️ #ESCCongress2024 #ESCCongress @BNordestgaard @SABOURETCardio @HolvenKirsten @ProfKausikRay @LaleTokgozoglu @TKDResmi